Patents by Inventor Kevin J. Hamblett

Kevin J. Hamblett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING EPIDERMAL GROWTH FACTOR DELETION MUTANT VIII RELATED DISORDERS
    Publication number: 20140314667
    Abstract: The present invention relates to methods of treating treating epidermal growth factor deletion mutant vIII (EGFRvIII) related disorders, such as glioblastoma or anaplastic astrocyte tumors, using antigen binding proteins, including antibodies against EGFRvIII conjugated to a drug. Diagnostic and therapeutic formulations of such antibodies and drug conjugates thereof are also provided.
    Type: Application
    Filed: November 16, 2012
    Publication date: October 23, 2014
    Applicant: AMGEN INC.
    Inventors: John Stephen Hill, Kevin J. Hamblett